Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : T.ITE: iTech Capital (TSE) -- Ignore unavailable to you. Want to Upgrade?

To: Crazy Canuck who wrote (3817)	1/20/2000 3:55:00 PM
From: Dan Hamilton	Respond to of 5053

Medibuy To Join Healtheon/WebMD in Supplies Site for Doctors SANTA CLARA, Calif. -- Medibuy.com and Healtheon/WebMD said the companies are creating an online site that will enable physicians to purchase medical and non-medical supplies. Medibuy, based in San Diego, sells medical supplies online. Under the agreement, it is to pay WebMD $45.5 million over a three-year period. Of that money, $10.7 million is to be paid this year, in exchange for becoming the "preferred" supply hub on WebMD's Internet site. Medibuy also will promote WebMD to its customers. In addition, WebMD will earn a share of transaction fees for all purchases made through the co-branded site. Healtheon/WebMD, a healthcare information provider, is publicly owned. Investors in Medibuy.com include Allianz Capital Partners, e-partners, Kleiner Perkins Caufield & Byers, Meritech Capital Partners, Oak Investment Partners, and Sequoia Capital. healtheon.com medibuy.com medibuy.com

To: Crazy Canuck who wrote (3817)	1/20/2000 4:20:00 PM
From: Barry K	Respond to of 5053

Yesterday, HealthGate filed for their IPO. Medsite was mentioned in their filing. Excerpts from their S1/A filing follow. Regards, Barry ____________________________________________________________ From the filing: THE COMPANY HealthGate is an Internet provider of reliable, objective, comprehensive and up-to-date healthcare information helping physicians and other healthcare professionals, patients and health-conscious consumers make better informed healthcare decisions. Common Stock This is an initial public offering of shares of common stock of HealthGate Data Corp. HealthGate expects that the public offering price will be between $9.00 and $11.00 per share. Our common stock has been approved for trading and quotation on the Nasdaq National Market under the symbol "HGAT." E-COMMERCE Currently, we use e-commerce to provide portions of our licensed content, including PsycINFO, CINAHL, the EMBASE Cardiology Consultant and full-text journals via the activePress service on a pay per view or transaction fee basis. In addition, we provide users the opportunity to purchase medical textbooks and other print products from MedBookStore, a Web-based medical bookstore offered by Medsite Publishing , and photocopies of articles not available from our collection of full-text journals from Infotrieve, a document delivery service. Also, users can subscribe to certain fee-based content sources on a monthly basis. We believe that significant opportunities exist to provide additional healthcare related products to professionals, patients and consumers using our technology platform and the HealthGate Network. In order to pursue these opportunities, we are exploring options for expanding the products and services currently offered using e-commerce. For example, as part of our agreement with SelfCare, we will share in e-commerce revenues generated from sales on the co-branded HealthGate/SelfCare Web site after we have provided a specific number of click-throughs to this Web site. We will continue to explore further opportunities in this area.

To: Crazy Canuck who wrote (3817)	1/21/2000 12:59:00 AM
From: Keith Minler	Read Replies (1) \| Respond to of 5053

WARNING:WILD SPECULATIONS AHEAD... WILD SPECULATIONS AHEAD Well Crazy I'll take a crack at crunching some numbers. We know that Medsite raised about 69 million. We know that JDX kicked in 1 million the first time. It seems a reasonable guess to think that they had to ante up 2 million more to stay even. So that means that they have put in 3 of 69 or 1/23 of capital. If the principles intend to retain say 75% of the company then Jdx would have 1/23 of 25% or 1.086 % of Medsite. If medsite IPO's to a similar value as Healtheon, say 6 billion; then JDX would have 1.086% of 6,000,000,000. or $65,160,000. If there are 35,000,000 shares outstanding in JDX, then the per share value of our holdings in Medsite would be $1.86. Which confirms most of us in our belief that JDX is way undervalued. Note:PURE SPECULATION...PURE SPECULATION...PURE SPECUALTION Anyone else have alternate guesses or hypotheses? Later Keith EDIT: Thinking about it, the above implies a return on investment for JDX of about 20 to 1, seems to me to be a tad high. Does anyone know what kind of return venture capital normally generates in these type situations? EDIT2:These figures are in US dollars, would mean about $2.75 CDN, I think, shouldn't do this type of stuff this late.